Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Vaxil Bio Ltd

VXL.V ✓ COMPLIANT ☆ Track — members

TSX Venture · Healthcare · Biotechnology & Medical Research ·

Canada Micro Cap Analyst: N/A

Last Close

$0.11

▲ +0.00%

Market Cap $457.61K · Vol 1.00K

Key Metrics

P/E Ratio

0.99

FWD: N/A

Market Cap

$457.61K

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

25.00

Momentum

Beta

-0.54

vs Market

52W High

$0.21

45.85% below

52W Low

$0.09

22.70% above

Volume

1.00K

Avg 877

P/B

0.42

Price-to-book

ROE

N/A

Return on equity

Free Float

94.39%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Vaxil Bio Ltd (VXL.V) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does VXL.V pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-8.57%

+3.23%

-39.62%

+14.29%

YTD

+10.34%

+0.00%

-79.39%

-96.00%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$379.63K
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	49.55% · N/A

P/E Ratio	0.99
Forward P/E (FY1)	N/A
PEG Ratio	0.00
P/S	N/A
P/B	0.42
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	3.98M

Technical Indicators

50-Day SMA	$0.12
200-Day SMA	$0.12
RSI (14)	25.00
Beta	-0.54
52-Week High	$0.21
52-Week Low	$0.09

Volume Today	1.00K
Avg Daily Volume (30D)	877
Relative Volume	1.14x
Volatility (10D)	42.51
Volatility (30D)	63.90
Free Float	94.39%

Analyst Consensus

N/A

Current Price $0.11

Mean Target N/A

52W Low$0.09 52W High$0.21

Current

Target

$0.09 $0.21

Current Analyst target

· 0 analysts

Identifiers

ExchangeTSX Venture

FIGIBBG001T6ZF46

ISINCA92243L2066

CountryCanada

Sub-IndustryBio Therapeutic Drugs

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

2359.HK WuXi AppTec Co Ltd -2.85% ARGX.BR argenx SE -3.21% ARGX argenx SE -0.66% INSM Insmed Inc -2.05% 2269.HK WuXi Biologics (Cayman) Inc -1.27%

Company Profile

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.